Mechanism of stachydrine inhibits ovarian cancer

DING Xin,WANG Qianyin,YANG Fazhen,ZHANG Zhongfei,ZHANG Yuanfang,QI Yuanfen,XIE Chengxia
DOI: https://doi.org/10.3969/j.issn.1000-484X.2023.03.018
2023-01-01
Abstract:Objective:To investigate inhibitory effect of stachydrine on apoptosis of ovarian cancer cell and its regulatory mechanism on endoplasmic reticulum stress(ERS) mediated endogenous apoptosis pathway. Methods:In vitro experiments, differences on survival rate, apoptosis rate, mRNA and protein expressions of apoptotic genes between blank control group(Con) and stachydrine low, medium and high doses groups(1, 8, 16 μmol/L) were compared. Nude mice transplanted tumor model was used to test effect of stachydrine on tumor formation of ovarian cancer cells in vivo. Results:Compared with Con group, proliferations of ovarian cancer cells SKOV3 in stachydrine low, medium, and high doses groups were significantly inhibited, apoptosis rates were significantly increased, mRNA expression of Bcl-2 was decreased significantly, mRNA expression of Caspase-3, protein expressions of CHOP and GRP78 were increased significantly, which in a dose-dependent manner(all P<0.05). Conclusion:Stachytine can inhibit proliferation of ovarian cancer cells SKOV3 and promote its apoptosis, whose mechanism may be activation of ERS mediated endogenous apoptosis pathway.
What problem does this paper attempt to address?